human
sever
acut
respiratori
syndrom
coronaviru
initi
report
guangdong
provinc
china
quickli
spread
almost
countri
result
infect
approxim
contain
public
health
quarantin
measur
sever
month
isol
close
relat
strain
horsesho
bat
suggest
potenti
reemerg
retransmiss
human
anim
reservoir
also
three
addit
human
sinc
shown
less
lethal
howev
sinc
april
fifteen
peopl
infect
recent
identifi
coronaviru
nine
die
pneumonia
renal
whole
genom
sequenc
character
show
close
similar
two
asian
bat
coronavirus
indic
signific
possibl
emerg
new
strain
sar
new
human
coronavirus
could
lead
even
deadli
outbreak
human
posit
rna
genom
contain
two
proteas
proteas
proteas
plpro
plpro
respons
cleavag
polyprotein
nonstructur
protein
first
three
posit
nonstructur
protein
cleav
plpro
wherea
eleven
posit
cleav
plpro
shown
essenti
viral
make
attract
drug
target
intens
pursu
drug
target
sever
inhibitor
report
categor
coval
peptidomimet
noncoval
peptidomimet
unlik
develop
plpro
inhibitor
limit
recent
despit
essenti
role
sar
viral
replic
addit
two
differ
type
plpro
inhibitor
report
recent
year
first
identifi
compound
screen
valu
second
sever
natur
product
diarylheptanoid
isol
alnu
japonica
show
inhibitori
activ
addit
primari
function
viral
peptid
cleavag
plpro
recogn
involv
deubiquitin
viral
evas
innat
immun
cystein
proteas
contain
zinc
bind
motif
catalyt
triad
domain
figur
sequenc
ident
similar
plpro
respect
support
inform
si
figur
interestingli
predict
structur
plpro
similar
si
figur
b
three
catalyt
residu
four
cystein
zinc
bind
motif
ident
two
plpro
enzym
addit
nine
highli
conserv
residu
mani
plpro
enzym
also
observ
plpro
highlight
yellow
si
figur
suggest
plpro
may
possess
characterist
similar
use
screen
ht
drug
design
previous
develop
seri
noncoval
plpro
inhibitor
show
promis
potenti
therapeut
inhibitor
shown
inhibitori
activ
valu
antivir
activ
see
tabl
inhibitor
structur
inhibitor
exhibit
inhibitori
activ
antivir
activ
inhibitor
repres
two
activ
chemic
scaffold
repres
first
scaffold
repres
second
scaffold
b
four
lead
inhibitor
show
moder
antivir
activ
potenc
must
improv
develop
clinic
candid
analysi
two
avail
plpro
structur
inhibitor
subsequ
molecular
model
studi
reveal
lead
inhibitor
bind
pocket
form
mostli
loop
side
chain
distinct
catalyt
site
shown
green
figur
inhibitor
appear
block
substrat
access
entranc
catalyt
site
plpro
enzym
scaffold
bind
similar
area
although
scaffold
inhibitor
block
littl
half
area
block
scaffold
b
inhibitor
one
way
improv
potenc
lead
inhibitor
would
optim
compound
expand
unoccupi
space
near
current
bind
site
would
requir
synthesi
larger
compound
process
consum
signific
amount
time
resourc
may
may
result
better
bind
affin
potenc
altern
strategi
applic
drug
design
fbdd
methodolog
becom
method
lead
mani
case
fbdd
use
discov
small
scaffold
optim
find
two
small
fragment
link
togeth
produc
potent
abl
link
two
small
fragment
typic
necessari
solv
crystal
structur
fragment
mani
case
obtain
structur
inform
challeng
due
typic
weak
bind
affin
fragment
target
enzym
studi
use
fbdd
combin
detail
enzymat
analysi
mean
optim
lead
inhibitor
without
use
crystallographi
test
small
librari
fragment
compound
presenc
lead
inhibitor
abl
identifi
fragment
synergist
improv
potenc
lead
inhibitor
addit
enzymat
analys
includ
mechan
inhibit
mutual
exclus
studi
describ
detail
comput
studi
use
predict
fragment
bind
locat
final
strategi
employ
predict
compound
abl
recapitul
bind
posit
lead
inhibitor
well
key
bind
featur
identifi
fragment
two
current
develop
plpro
inhibitor
scaffold
bind
catalyt
site
plpro
proteas
separ
nearbi
bind
site
cradl
residu
bind
loop
leav
catalyt
site
unoccupi
inhibit
although
catalyt
pocket
small
reason
probabl
fragment
compound
could
success
bind
locat
enhanc
inhibitori
activ
lead
inhibitor
zenobia
librari
consist
chemic
structur
divers
compound
experiment
screen
presenc
four
previous
discov
lead
inhibitor
fragment
compound
test
continu
kinet
enzymat
assay
describ
experiment
section
replic
plot
inhibitor
fragment
show
highli
reproduc
result
si
figur
replic
plot
lead
inhibitor
similar
inhibitor
compound
fragment
show
increas
enzym
inhibit
test
fragment
concentr
presenc
inhibitor
respect
percentag
effici
indic
pei
fragment
calcul
hit
select
criteria
accord
method
et
al
percent
inhibit
divid
molecular
weight
r
compound
pei
valu
greater
classifi
hit
compound
pei
select
test
high
compound
classifi
outlier
due
strong
likelihood
nonspecif
histogram
pei
valu
fragment
combin
four
lead
inhibitor
shown
si
figur
b
total
fragment
medium
pei
rang
select
studi
valu
select
fragment
absenc
lead
inhibitor
first
determin
valu
vari
fragment
fragment
summar
tabl
next
valu
four
lead
inhibitor
determin
presenc
compound
compound
eight
fragment
show
synergist
enhanc
valu
decreas
threefold
least
one
lead
inhibitor
valu
inhibitor
enhanc
fragment
respect
rel
lead
inhibitor
alon
tabl
fragment
show
strongest
synergi
inhibitor
enhanc
valu
two
fragment
also
equal
enhanc
inhibitor
valu
inhibitor
enhanc
respect
fragment
compound
improv
valu
inhibitor
fragment
appear
better
synergi
scaffold
b
inhibitor
repres
scaffold
fragment
also
show
signific
synergist
activ
inhibitor
respect
six
eight
fragment
exhibit
revers
enzym
recoveri
wherea
respect
recoveri
rate
plpro
cystein
proteas
contain
cystein
activ
site
partial
irrevers
fragment
may
coval
interact
residu
coval
interact
compound
like
nonspecif
reactiv
usual
toxic
issu
therefor
fragment
may
good
candid
although
best
enhanc
scaffold
b
inhibitor
inhibitor
similarli
result
indic
fragment
may
also
exhibit
problem
irrevers
two
indic
bind
effici
index
bei
surfac
bind
effici
index
sei
calcul
bei
relat
potenc
molecular
weight
compound
sei
index
monitor
potenc
gain
polar
surfac
area
psa
increas
bei
sei
eight
fragment
four
lead
inhibitor
calcul
simpl
equat
divid
r
bei
divid
psa
psa
valu
import
indic
relat
oral
bioavail
intestin
bei
valu
fragment
suggest
outlier
due
possibl
nonspecif
interact
si
figur
c
fragment
contain
aldehyd
like
exhibit
nonspecif
affin
cystein
residu
catalyt
site
plpro
enzym
thu
consid
ligand
effici
indic
enzym
activ
recoveri
rate
fragment
best
enhanc
inhibitor
respect
although
observ
valu
enhanc
fragment
curv
use
enzymat
assay
possibl
result
could
due
nonspecif
interact
plpro
enzym
fragment
enzym
assay
alon
lead
fals
posit
case
investig
orthogon
bind
analys
surfac
plasmon
reson
spr
perform
dissoci
equilibrium
constant
k
reflect
bind
affin
determin
four
lead
inhibitor
seven
newli
identifi
fragment
fragment
exclud
studi
due
low
enhanc
bind
affin
inhibitor
vari
determin
spr
rang
similar
valu
tabl
figur
promisingli
bind
affin
fragment
respect
k
fit
curv
shown
figur
b
exampl
howev
three
fragment
suspect
form
nonspecif
interact
due
unusu
high
bei
valu
note
spr
analys
confirm
three
fragment
well
fragment
bind
nonspecif
fragment
show
typic
curv
concentr
increas
instead
show
random
bind
pattern
shown
figur
c
fragment
show
typic
curv
spr
respons
unit
increas
nearli
ru
concentr
increas
figur
like
due
multisit
bind
caus
aggreg
rather
interact
plpro
enzym
suggest
fragment
may
bind
mani
differ
locat
plpro
enzym
mechan
inhibit
studi
thoroughli
describ
lead
inhibitor
prior
studi
suggest
inhibitor
behav
competit
two
crystal
structur
compound
verifi
bind
entranc
catalyt
site
block
substrat
access
site
although
lead
inhibitor
bind
directli
catalyt
site
nonetheless
display
competit
inhibit
pattern
thoroughli
investig
inhibit
mechan
lead
inhibitor
fragment
compound
kinet
studi
compound
perform
complex
vari
substrat
concentr
data
fit
four
equat
eq
experiment
section
three
plot
dixon
use
sigmaplot
enzym
kinet
modul
akaik
inform
aicc
valu
use
determin
best
fit
lowest
aicc
valu
correspond
best
fit
equat
determin
equat
fit
best
aicc
valu
differ
must
least
two
unit
next
four
previous
develop
lead
inhibitor
show
noncompetit
inhibit
unequ
bind
affin
free
enzym
e
enzym
es
alpha
valu
equal
tabl
four
lead
inhibitor
show
valu
greater
indic
bind
affin
free
enzym
tighter
es
dixon
plot
noncompetit
inhibit
inhibitor
respect
substrat
shown
figur
result
k
valu
three
fragment
show
noncompetit
inhibit
differ
valu
well
fragment
valu
greater
indic
fragment
also
behav
similarli
lead
inhibitor
although
valu
fragment
smaller
lead
inhibitor
may
explain
display
strongest
effect
three
lead
inhibitor
wherea
fragment
exhibit
strongest
synergist
effect
scaffold
b
inhibitor
dixon
plot
noncompetit
inhibit
fragment
shown
figur
b
k
valu
determin
four
lead
inhibitor
two
fragment
show
noncompetit
inhibit
like
compound
bind
anoth
site
catalyt
site
hinder
substrat
bind
enzym
therefor
studi
suggest
unlik
newli
identifi
compound
bind
catalyt
site
plpro
enzym
mechan
inhibit
bind
synergymutu
exclus
analys
determin
newli
identifi
compound
bind
site
separ
lead
inhibitor
unfortun
inform
insuffici
identifi
fragment
bind
plpro
enzym
therefor
investig
possibl
bind
site
candid
unexplor
catalyt
pocket
design
candid
fragment
bind
site
although
mechan
inhibit
studi
indic
locat
like
fragment
bind
site
identifi
addit
candid
fragment
bind
site
perform
seri
comput
solvent
map
experi
hot
spot
analys
use
ftmap
server
see
experiment
section
ftmap
multistag
protein
map
algorithm
base
fast
fourier
transform
fft
correl
approach
effici
search
potenti
bind
site
entir
surfac
protein
two
model
system
crystal
structur
inhibitor
bound
plpro
pdb
id
inhibitor
bound
plpro
pdb
id
use
analys
two
provid
repres
crystal
structur
compound
scaffold
use
ns
molecular
dynam
md
simul
system
determin
major
fluctuat
structur
come
zinc
bind
motif
sheet
form
catalyt
triad
repres
snapshot
structur
extract
simul
discuss
see
experiment
section
submit
ftmap
server
perform
bind
site
analysi
two
strong
candid
fragment
bind
site
identifi
analyz
origin
structur
consensu
cluster
probe
molecul
use
see
experiment
section
two
hot
spot
identifi
analysi
includ
extens
origin
bind
site
lead
inhibitor
one
caviti
palm
region
shown
figur
hot
spot
larger
lead
inhibitor
bind
site
includ
addit
caviti
unoccupi
lead
inhibitor
bind
site
previous
discuss
possibl
substrat
recognit
extend
caviti
compos
five
residu
second
posit
identifi
ftmap
hot
spot
locat
away
lead
inhibitor
bind
site
catalyt
site
plpro
encompass
zinc
bind
motif
palm
region
lastli
small
volum
contain
catalyt
triad
site
identifi
ftmap
like
due
smaller
size
pocket
structur
analysi
comput
studi
identifi
four
potenti
fragment
bind
site
three
locat
within
bind
site
lead
inhibitor
candid
bind
site
shown
green
unoccupi
catalyt
pocket
figur
b
identifi
analysi
structur
avail
candid
bind
site
identifi
ftmap
use
comput
solvent
map
discuss
experiment
section
surround
residu
candid
bind
site
locat
right
lead
inhibitor
bind
site
figur
c
shown
blue
addit
coars
dock
studi
hit
fragment
compound
see
experiment
section
identifi
anoth
shallow
bind
site
design
candid
bind
site
shown
orang
figur
c
mechan
inhibit
analys
mutual
exclus
studi
discuss
indic
fragment
bind
combin
lead
inhibitor
distinct
separ
bind
site
enzym
import
observ
lay
foundat
futur
merg
link
studi
propos
investig
candid
fragment
bind
site
predict
like
bind
conform
fragment
within
site
perform
seri
comput
bind
free
energi
calcul
studi
describ
detail
experiment
section
use
combin
molecular
dock
molecular
simul
molecular
surfac
area
mmpbsa
calcul
predict
bind
free
energi
bind
lead
inhibitor
synergist
fragment
place
adjac
candid
bind
site
studi
perform
use
three
potenti
bind
site
site
catalyt
site
site
extend
lead
inhibitor
bind
site
site
identifi
coars
dock
hot
spot
exclud
studi
due
larg
distanc
inhibitor
bind
site
hot
spot
shallow
highli
expos
locat
zinc
bind
motif
palm
region
see
figur
importantli
appear
like
even
bind
small
fragment
posit
could
caus
degre
conform
chang
two
region
structur
chang
would
like
affect
lead
inhibitor
bind
site
enhanc
valu
extent
observ
reason
well
impract
fragment
link
merg
strategi
distanc
hot
spot
exclud
analys
calcul
free
energi
bind
lead
inhibitor
fragment
place
success
candid
site
compar
experiment
determin
bind
affin
lead
inhibitor
synergist
fragment
predict
like
fragment
bind
site
purpos
studi
bind
conform
inhibitor
structur
repres
scaffold
b
use
fragment
select
use
studi
due
strong
synergist
effect
inhibitor
fragment
dock
three
candid
bind
site
discuss
three
dock
pose
fragment
select
simul
see
experiment
section
simul
result
mmpbsa
allow
calcul
bind
free
energi
lead
inhibitor
simul
shown
figur
initi
note
fragment
stabl
bind
site
repeatedli
drift
site
ns
mark
regardless
start
posit
suggest
shallow
bind
site
also
appropri
posit
fragment
bind
henc
site
also
remov
consider
analysi
site
perform
addit
analysi
mmpbsa
result
figur
si
tabl
reveal
catalyt
site
site
also
favor
posit
fragment
bind
bind
free
energi
valu
inhibitor
fragment
posit
higher
calcul
inhibitor
alon
well
experiment
deriv
result
result
taken
togeth
experiment
result
discuss
indic
catalyt
site
like
bind
site
identifi
synergist
fragment
favor
result
close
align
experiment
valu
obtain
howev
fragment
place
bind
site
shown
figur
consist
synergist
activ
note
prefer
posit
charg
observ
piperazin
amin
group
place
anion
pocket
site
defin
combin
establish
bind
featur
lead
inhibitor
result
clear
gain
calcul
bind
affin
addit
stack
interact
naphthalen
ring
system
aromat
ring
system
fragment
visibl
figur
may
stabil
lead
inhibitor
bind
conform
priorit
compound
candid
futur
synthesi
test
undertook
seri
dock
analys
use
inform
determin
bind
site
predict
studi
discuss
strategi
involv
elimin
potenti
problemat
nitroaromat
ring
fragment
direct
incorpor
piperazin
ring
lead
inhibitor
scaffold
shown
figur
seri
propos
compound
design
use
varieti
link
group
posit
discuss
experiment
section
dock
extend
bind
site
defin
lead
inhibitor
bind
site
tabl
propos
compound
select
score
abil
success
recapitul
key
bind
featur
inhibitor
synergist
fragment
includ
lipophil
interact
naphthalen
ring
system
posit
posit
charg
amin
piperazin
key
anion
pocket
discuss
attempt
improv
potenc
current
develop
lead
plpro
inhibitor
librari
enzymat
test
combin
four
lead
inhibitor
discov
total
eight
compound
synergist
enhanc
inhibitori
activ
lead
inhibitor
orthogon
bind
analysi
spr
confirm
bind
three
fragment
also
determin
direct
bind
affin
k
character
assay
bind
mechan
two
newli
identifi
fragment
compound
show
noncompetit
inhibit
indic
synergist
fragment
compound
bind
catalyt
site
plpro
enzym
comput
analysi
predict
sever
potenti
fragment
bind
site
expans
studi
reveal
prefer
fragment
bind
site
extens
lead
inhibitor
bind
site
inhibitor
bind
site
occupi
repres
structur
enzymat
character
comput
studi
suggest
fragment
bind
adjac
bind
site
lead
inhibitor
abl
stabil
state
use
structur
inform
reveal
studi
abl
appli
strategi
suggest
sever
compound
high
predict
bind
affin
novel
approach
describ
herein
may
benefici
case
direct
crystal
studi
prove
difficult
fragment
bind
site
analysi
md
simul
perform
use
amber
suit
program
amber
two
known
structur
pdb
id
obtain
rcsb
protein
data
bank
multim
protein
complex
reduc
function
monom
form
simul
bound
inhibitor
zinc
ion
retain
system
ion
crystal
water
remov
ligand
paramet
gener
use
antechamb
softwar
ambertool
v
gener
amber
forc
field
gaff
leap
use
neutral
system
ad
sodium
ion
system
solvat
use
water
rectangular
box
system
prepar
use
forc
minim
use
sander
carri
two
step
first
water
molecul
minim
step
keep
protein
fix
second
entir
system
minim
addit
step
period
boundari
condit
appli
nonbond
cutoff
system
heat
k
use
nvt
ensembl
ps
posit
restraint
protein
follow
system
equilibr
ps
use
npt
ensembl
without
restraint
product
phase
simul
perform
use
npt
ensembl
without
posit
restraint
ns
perform
use
ptraj
modul
ambertool
v
comput
averag
structur
everi
ns
write
pdb
file
averag
coordin
total
snapshot
extract
use
method
pdb
file
gener
upload
ftmap
server
http
ftmapbuedu
ftmap
server
remov
water
ion
bound
ligand
retain
protein
structur
sixteen
differ
probe
use
ethanol
isopropanol
isobutanol
aceton
acetaldehyd
dimethyl
ether
cyclohexan
ethan
acetonitril
urea
methylamin
phenol
benzaldehyd
benzen
acetamid
n
output
result
gener
ftmap
form
pdb
file
consensu
cluster
differ
probe
map
surfac
plpro
structur
cluster
site
identifi
ftmap
requir
conserv
among
molecular
probe
select
studi
describ
two
site
identifi
see
discuss
one
addit
candid
bind
site
site
identifi
use
coars
dock
studi
describ
bind
affin
predict
investig
potenti
bind
site
fragment
dock
enzym
use
extra
precis
induc
fit
dock
ifd
protocol
use
default
structur
plpro
bound
pdb
id
pdb
id
obtain
rcsb
protein
data
bank
prior
molecular
dock
structur
protein
target
prepar
use
protein
prepar
wizard
softwar
packag
suit
water
molecul
crystal
structur
remov
crystal
multim
reduc
monom
residu
locat
within
bound
inhibitor
refin
prime
algorithm
two
distinct
dock
run
perform
use
strategi
first
dock
run
blind
dock
coars
dock
dock
area
defin
within
lead
inhibitor
candid
site
identifi
studi
bind
site
multipl
fragment
subsequ
dock
run
defin
locat
candid
site
identifi
structur
comput
analys
describ
bind
site
catalyt
site
defin
select
residu
bind
site
defin
select
residu
bind
site
defin
select
residu
bind
hot
spot
studi
reason
describ
case
dock
area
defin
box
center
select
residu
fragment
zenobia
librari
prepar
multipl
tautom
proton
state
ph
use
ligprep
eight
activ
fragment
dock
coars
dock
studi
fragment
dock
subsequ
candid
site
dock
studi
dock
pose
rank
glide
xp
second
dock
run
three
conform
pose
bind
site
site
produc
ifd
select
start
conform
md
simul
subsequ
mmpbsa
calcul
describ
bind
pose
select
includ
top
score
pose
two
pose
possess
greatest
differ
calcul
rmsd
md
simul
subsequ
mmpbsa
calcul
use
predict
bind
affin
perform
use
amber
suit
program
amber
prepar
md
simul
includ
parameter
fragment
inhibitor
prepar
equilibr
system
perform
exactli
describ
bind
site
analys
product
phase
simul
perform
use
npt
ensembl
without
posit
restraint
ns
python
script
mmpbsapi
includ
amber
use
perform
mmpbsa
first
frame
last
ns
equilibr
simul
trajectori
file
use
mmpbsa
calcul
ionic
strength
set
intern
dielectr
constant
set
default
option
set
default
set
valu
free
energi
bind
inhibitor
combin
three
differ
fragment
pose
calcul
accord
equat
equat
imag
g
complex
calcul
gibb
free
energi
complex
g
receptor
gibb
free
energi
complex
g
ligand
gibb
free
energi
calcul
inhibitor
compound
free
energi
valu
term
estim
sum
four
term
equat
imag
e
mm
molecular
mechan
energi
molecul
express
sum
intern
energi
molecul
plu
electrostat
van
der
waal
interact
g
psolv
polar
contribut
solvat
energi
molecul
g
npsolv
nonpolar
solvat
energi
absolut
temperatur
vibrat
rotat
translat
entropi
molecul
estim
normal
mode
analysi
use
five
regularli
space
snapshot
first
frame
last
ns
md
simul
ionic
strength
normal
mode
calcul
set
fragment
merg
dock
fragment
merg
strategi
employ
base
bind
conform
observ
mmpbsa
studi
figur
propos
compound
design
merg
structur
lead
inhibitor
fragment
nitroaromat
ring
delet
remain
piperazin
ring
attach
sever
differ
site
lead
inhibitor
use
varieti
differ
link
group
goal
retain
lead
bind
posit
inhibitor
scaffold
dock
merg
hybrid
investig
sever
altern
link
strategi
includ
link
naphthalen
ring
chiral
methyl
group
scaffold
methylenedioxybenzen
scaffold
b
alkyl
group
ester
group
amid
group
bind
conform
virtual
gener
hybrid
collect
predict
use
glide
dock
sp
score
structur
plpro
bound
pdb
id
pdb
id
use
dock
studi
prepar
use
protein
prepar
softwar
describ
dock
site
defin
box
center
origin
bind
site
lead
inhibitor
hybrid
compound
librari
prepar
describ
fragment
inhibitor
dock
propos
compound
discuss
select
score
visual
comparison
crystallograph
posit
lead
inhibitor
predict
bind
conform
fragment
replic
plot
ligand
effici
indic
bind
free
energi
calcul
nmr
spectra
fragment
hit
compound
includ
support
inform
